PHBBF (Pharmaron Beijing Co) Total Debt per Share: $0.56 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHBBF Pharmaron Beijing Co Ltd PHBBF
81 GF Score
Price $1.93
GF Value $1.32
! 9 Warning Signs
View Full Analysis

What is Pharmaron Beijing Co Total Debt per Share?

Pharmaron Beijing Co PHBBF 81 Total Debt per Share is $0.56 as of Jun. 2026. GuruFocus rates PHBBF with a GF Score™ of 81/100 and a GF Value™ of $1.32. The stock has 9 warning signs investors should review.

$0.56 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmaron Beijing Co's Total Debt Per Share for the quarter that ended in Jun. 2026 was $0.56.

Pharmaron Beijing Co Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Pharmaron Beijing Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaron Beijing Co Total Debt per Share Chart

Pharmaron Beijing Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.49 0.76 0.46 0.56

Pharmaron Beijing Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.50 0.56 0.56 0.56
PHBBF
81GF Score
Pharmaron Beijing Co Ltd PHBBF
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaron Beijing Co Total Debt per Share Calculation

Pharmaron Beijing Co's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(305+694)/1,778
=0.56

Pharmaron Beijing Co's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(335+691)/1,837
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $0.56 mean?
Pharmaron Beijing Co (PHBBF) has a Total Debt per Share of $0.56 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Pharmaron Beijing Co and its competitors.
Is Pharmaron Beijing Co's Total Debt per Share too high?
Pharmaron Beijing Co's current Total Debt per Share is $0.56. Overall, Pharmaron Beijing Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaron Beijing Co's Total Debt per Share compare to VRTX and REGN?
Pharmaron Beijing Co's Total Debt per Share of $0.56 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Pharmaron Beijing Co and its competitors. Pharmaron Beijing Co's current Total Debt per Share is $0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaron Beijing Co stock overvalued right now?
Pharmaron Beijing Co (PHBBF) has a current Total Debt per Share of $0.56. The stock's GF Value™ is $1.32, compared to a current price of $1.93 — trading 46.2% above its estimated fair value. The current Total Debt per Share is $0.56. Pharmaron Beijing Co's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Pharmaron Beijing Co (PHBBF), the current Total Debt per Share is $0.56 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaron Beijing Co (PHBBF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaron Beijing Co stock appears to be overvalued. The current stock price of $1.93 is trading 46.2% above its estimated GF Value™ of $1.32.

Key valuation signals for PHBBF:

  • Total Debt per Share: $0.56
  • GF Value™: $1.32 vs. price of $1.93 (46.2% above fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the PHBBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaron Beijing Co Business Description

Address 6 Tai-He Road, 8th Floor, Block 1, Beijing Economic Technological Development Area, Beijing, CHN, 100176
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
81GF Score

Get the complete analysis for PHBBF

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.93
Price
$1.32
GF Value